[Treatment of duodenal ulcer with rosaprostol in patients resistant to treatment with anti-H2].
The results obtained with the combined treatment Rosaprostol + anti-H2 in 10 patients with duodenal ulcer previously treated with insufficient results with anti-H2 drugs are described (in comparison with other 10 patients under the same conditions treated with anti-H2 alone). The results are clearly favourable (statistical significance) for Rosaprostol. The drug was well tolerated.
D000328:Adult; D000536:Aluminum Hydroxide / Q000627:therapeutic use; D000897:Anti-Ulcer Agents / Q000627:therapeutic use*; D004338:Drug Combinations / Q000627:therapeutic use; D004341:Drug Evaluation; D004351:Drug Resistance; D004359:Drug Therapy, Combination; D004381:Duodenal Ulcer / Q000188:drug therapy*; D005227:Fatty Acids / Q000627:therapeutic use*; D005260:Female; D006635:Histamine H2 Antagonists / Q000627:therapeutic use; D006801:Humans; D008276:Magnesium Hydroxide / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D011466:Prostanoic Acids / Q000627:therapeutic use*
D000897:Anti-Ulcer Agents; D004338:Drug Combinations; D005227:Fatty Acids; D006635:Histamine H2 Antagonists; D011466:Prostanoic Acids; C013591:aluminum hydroxide, magnesium hydroxide, drug combination; D000536:Aluminum Hydroxide; D008276:Magnesium Hydroxide; C035288:rosaprostol
Il trattamento dell'ulcera duodenale con rosaprostol in pazienti resistenti al trattamento con anti-H2.